What outcomes are important to patients with mild cognitive impairment or Alzheimers disease their caregivers and health-care professionals? A systematic review

摘要

IntroductionClinical trials involving patients with Alzheimer's disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease most relevant to key stakeholders.